PRCP: A Potential Drug Target for Cancer (G5547)

Target Name: PRCP

NCBI ID: G5547

PRCP

PRCP: A Potential Drug Target for Cancer

PRCP, or poly(ADP-ribose) polymerase, is a protein that is involved in the regulation of DNA replication in eukaryotic cells. It is a key enzyme in the replication of DNA in the cytosol of the cell, and is essential for the proper functioning of the cell. PRCP has been identified as a potential drug target in the field of cancer, due to its involvement in the regulation of cell division and its potential to inhibit the growth of cancer cells.

One of the key features of PRCP is its role in the regulation of DNA replication. DNA replication is the process by which a cell makes an exact copy of its genetic material, and it is a critical process for the development and maintenance of the cell. PRCP is involved in the regulation of DNA replication by helping to ensure that the copies of the DNA are made accurately and completely.

In addition to its role in DNA replication, PRCP has also been shown to have a number of other functions. For example, it has been shown to play a role in the regulation of gene expression, and it has been shown to be involved in the stress response of the cell. PRCP has also been shown to be involved in the regulation of cell adhesion, and it has been shown to play a role in the development and maintenance of cancer.

Due to its involvement in so many important cellular processes, PRCP has been identified as a potential drug target in the field of cancer. By inhibiting the activity of PRCP, researchers hope to be able to inhibit the growth of cancer cells and potentially lead to the development of a new treatment for cancer.

In conclusion, PRCP is a protein that is involved in the regulation of DNA replication in eukaryotic cells. It is a key enzyme in the replication of DNA and has been shown to play a number of important roles in the functioning of the cell. As a result, PRCP has been identified as a potential drug target in the field of cancer, and research is ongoing to determine its potential effectiveness as a treatment for this disease.

Protein Name: Prolylcarboxypeptidase

Functions: Cleaves C-terminal amino acids linked to proline in peptides such as angiotensin II, III and des-Arg9-bradykinin. This cleavage occurs at acidic pH, but enzymatic activity is retained with some substrates at neutral pH

The "PRCP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRCP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets